Current role
Preetam Shah
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Preetam Shah
The proxy statement of Elicio Therapeutics, Inc. reports total compensation of $1,377,686 for Preetam Shah in fiscal 2025, including a base salary of $350,612. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Elicio Therapeutics, Inc. (ELTX)
Proxy statement
CurrentStart not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Elicio Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Jennifer J. Rhodes General Counsel
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Elicio Therapeutics, Inc. (ELTX) | Ph.D., Chief Strategy and Financial Officer and Treasurer | $350,612 | $1,377,686 |
| 2024 | Elicio Therapeutics, Inc. (ELTX) | Ph.D., Chief Strategy and Financial Officer and Treasurer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.